Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies
- PMID: 35213025
- PMCID: PMC9703260
- DOI: 10.1007/978-1-0716-2010-6_19
Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies
Abstract
Antisense oligonucleotide (AON)-based splice modulation is the most widely used therapeutic approach to redirect precursor messenger RNA (pre-mRNA) splicing. To study the functional effect of human mutations affecting pre-mRNA splicing for which AON-based splice redirection would be a potential therapeutic option, humanized knock-in animal models are pivotal. A major limitation of using humanized animal models for this purpose is the reported poor recognition of human splice sites by the splicing machineries of other species. To overcome this problem, we provide a detailed guideline for the generation of functional humanized knock-in zebrafish models to assess the effect of mutation-induced aberrant splicing and subsequent AON-based splice modulation therapy .
Keywords: Antisense oligonucleotides; Inherited retinal dystrophies; Pre-mRNA splicing; Species-specific minigene splice assay; Usher syndrome; Zebrafish.
© 2022. The Author(s).
Similar articles
-
Poor Splice-Site Recognition in a Humanized Zebrafish Knockin Model for the Recurrent Deep-Intronic c.7595-2144A>G Mutation in USH2A.Zebrafish. 2018 Dec;15(6):597-609. doi: 10.1089/zeb.2018.1613. Epub 2018 Oct 3. Zebrafish. 2018. PMID: 30281416
-
Design and In Vitro Use of Antisense Oligonucleotides to Correct Pre-mRNA Splicing Defects in Inherited Retinal Dystrophies.Methods Mol Biol. 2018;1715:61-78. doi: 10.1007/978-1-4939-7522-8_5. Methods Mol Biol. 2018. PMID: 29188506
-
Antisense Oligonucleotide Therapy for Inherited Retinal Dystrophies.Adv Exp Med Biol. 2016;854:517-24. doi: 10.1007/978-3-319-17121-0_69. Adv Exp Med Biol. 2016. PMID: 26427454 Review.
-
Antisense Oligonucleotide Design and Evaluation of Splice-Modulating Properties Using Cell-Based Assays.Methods Mol Biol. 2018;1828:519-530. doi: 10.1007/978-1-4939-8651-4_34. Methods Mol Biol. 2018. PMID: 30171565
-
Modification of pre-mRNA splicing by antisense oligonucleotides.Acta Biochim Pol. 1997;44(2):231-7. Acta Biochim Pol. 1997. PMID: 9360712 Review.
Cited by
-
Exploring non-coding variants and evaluation of antisense oligonucleotides for splicing redirection in Usher syndrome.Mol Ther Nucleic Acids. 2024 Oct 28;35(4):102374. doi: 10.1016/j.omtn.2024.102374. eCollection 2024 Dec 10. Mol Ther Nucleic Acids. 2024. PMID: 39629117 Free PMC article.
-
Experimental Model Systems Used in the Preclinical Development of Nucleic Acid Therapeutics.Nucleic Acid Ther. 2023 Aug;33(4):238-247. doi: 10.1089/nat.2023.0001. Epub 2023 May 5. Nucleic Acid Ther. 2023. PMID: 37145922 Free PMC article.
-
Small Fish, Big Answers: Zebrafish and the Molecular Drivers of Metastasis.Int J Mol Sci. 2025 Jan 21;26(3):871. doi: 10.3390/ijms26030871. Int J Mol Sci. 2025. PMID: 39940643 Free PMC article. Review.
References
-
- Liu MM, Zack DJ (2013) Alternative splicing and retinal degeneration. Clin Genet 84:142–149. https://doi.org/10.1111/cge.12181 doi: 10.1111/cge.12181. - DOI - PMC - PubMed
-
- Cremers FP, van de Pol DJ, van Driel M et al (1998) Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt’s disease gene ABCR. Hum Mol Genet 7:355–362. https://doi.org/10.1093/hmg/7.3.355 doi: 10.1093/hmg/7.3.355. - DOI - PubMed
-
- Hollander den AI, Koenekoop RK, Yzer S et al (2006) Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis. Am J Hum Genet 79:556–561. https://doi.org/10.1086/507318 doi: 10.1086/507318. - DOI - PMC - PubMed
-
- Thompson DA, Gyürüs P, Fleischer LL et al (2000) Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci 41:4293–4299 - PubMed
-
- Vaché C, Besnard T, le Berre P et al (2012) Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy. Hum Mutat 33:104–108. https://doi.org/10.1002/humu.21634 doi: 10.1002/humu.21634. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources